TobiasSamuelDoryCohenMDPhD(He/Him)

PubMed

• 2 citations
  Granulocyte Transfusion: Clinical Updates and a Practical Approach to Transfusion.
  Tobias Cohen, Sierra C. Simmons, Huy P. Pham, Elizabeth M. Staley> ;Clinics in Laboratory Medicine. 2021 Sep 29
• 4 citations
  Valspodar limits human cytomegalovirus infection and dissemination.
  Andrea J. Parsons, Tobias Cohen, Toni M. Schwarz, Kathryn R. Stein, Sabrina I. Ophir, Jailene Paredes Casado, Domenico Tortorella> ;Antiviral Research. 2021 Jun 28
• 18 citations
  The strengths and weaknesses of viscoelastic testing compared to traditional coagulation testing.
  Tobias Cohen, Thorsten Haas, Melissa M. Cushing> ;Transfusion. 2020 Oct 22
• 23 citations
  Convallatoxin-induced reduction of methionine import effectively inhibits human cytomegalovirus infection and replication
  Tobias Cohen, John D. Williams, Timothy J. Opperman, Roberto Sanchez, Nell S. Lurain, Domenico Tortorella> ;Journal of Virology. 2016 Nov 14
• 14 citations
  The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus.
  Tobias Cohen, Toni M. Schwarz, Frederic Vigant, Thomas J. Gardner, Rosmel E. Hernandez, Benhur Lee, Domenico Tortorella> ;Viruses. 2016 Oct 24
• 28 citations
  Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle.
  Thomas J. Gardner, Tobias Cohen, Veronika Redmann, Zerlina Lau, Dan P. Felsenfeld, Domenico Tortorella> ;Antiviral Research. 2015 Jan 1
• 13 citations
  Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
  Michael Y. Xiong, Amilcar E. Rizzo, Tobias Cohen, Robert K. Dyer, Kaveri Korgavkar, Stephen F. Bingham, Martin A. Weinstock> ;The Journal of Investigative Dermatology. 2013 Jun 1
• 23 citations
  Predictors of Basal Cell Carcinoma in High-Risk Patients in the VATTC (VA Topical Tretinoin Chemoprevention) Trial
  Robert K. Dyer, Martin A. Weinstock, Tobias Cohen, Amilcar E. Rizzo, Stephen F. Bingham> ;The Journal of Investigative Dermatology. 2012 Nov 1
• 83 citations
  A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM).
  Tobias Cohen, Leonard Moise, Matthew Ardito, William J. Martin, Anne S. De Groot> ;Journal of Biomedicine & Biotechnology. 2010 Jul 18
• Species neutral correlates of immunogenicity for vaccines and protein therapeutics: fact or science fiction.
  Anne S. De Groot, Matthew Baker, Tobias Cohen> ;Human Vaccines. 2010 May 1
• Join now to see all

Books/Book Chapters

• Methods in Microbiology 
  Chapter: Use of Bioinformatics to Predict MHC Ligands and T-Cell Epitopes: Application to Epitope-Driven Vaccine Design 
  Page 35 - 66De Groot AS, Cohen T, Ardito M, Moise L, Martin W, Berzofsky JEditors: Kabelitz D and Kaufmann SHE.Academic PressEdition 37,2010
• Infectious Disease Informatics 
  Chapter: Immunoinformatics: The Next Step in Vaccine Design 
  Page 223 - 244Cohen T, Moise L, Martin W, De Groot ASEditors: Sintchenko, V.SpringerEdition 1,2009
• Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009 
  Chapter: Reducing Protein Immunogenicity by Design: Deimmunization and Tolerance Induction 
  Page 525 - 534De Groot AS, Cohen T, Moise L, Martin WDEditors: Jenkins N, Barron N, Alves P.Springer2011

Abstracts/Posters

• Effect of Temporary Storage of Cryopreserved Cellular Therapy Products at -80 Degrees Celsius on Cell Recovery and Viability
  Tobias Cohen and Yvette Tanhehco, ISCT Annual Meeting 2024, Vancouver, CA, 5/2024
• Characterization of Use of Cryoprecipitate in Perioperative Bleeding
  Cushing MM, Rand S, Fitzgerald M, Cohen T, Rajendran R, Littlejohn J, Hill S, Ivascu N, DeSimone RA, AABB Annual Meeting 2022, Virtual, 11/6/2022
• Reducing Emergency Department Specimen Rejection by the Blood Bank: An ED-BB Collaboration
  Cohen T, Golden DL, Jacobowitz AM, Gibson C, Hennessy C, Lo D, McCarty M, DeSimone RA, Shemesh A, 2021 Blood Bank Association of New York State Annual Meeting, Virtual, 6/3/2021
• Inhibition of P-glycoprotein by Valspodar Inhibits Cytomegalovirus Infection
  Cohen T, Schwarz TM, Hernandez RE, Gardner TJ, Tortorella D, 54th Annual Meeting of the Academy of Clinical Laboratory Physicians and Scientists, Salt Lake City, Utah, 5/31/2019
• Exploiting Small Molecule Drugs to Study Cytomegalovirus Infection
  Cohen T, Gardner TJ, Schwarz T, Williams JD, Redmann V, Lau Z, Vigant F, Opperman TJ, Hernandez RE, Sanchez R, Lurain N, Lee B, Felsenfeld D, Tortorella D, 22nd Annual Medical Student Research Day, Icahn School of Medicine at Mount Sinai, 3/16/2017
• Discovering Structural Elements Important for a Novel Cell Free and Cell Associated Cytomegalovirus Inhibitor
  Cohen T, Williams JD, Sanchez R, Lurain N, Tortorella D, 28th Symposium on Virus-Host Interactions, New York Academy of Medicine, 1/14/2016
• The Role of Ion Transport in Establishing Cytomegalovirus Infections.
  Cohen T, Gardner TJ, Noriega VM, Williams JD, Tortorella D, 40th International Herpesvirus Workshop, Boise, Idaho, 7/25/2015
• Repurposing Small Molecule Drugs for Congenital Cytomegalovirus
  Cohen T, Gardner TJ, Noriega VM, Williams JD, Tortorella D, 27th Symposium on Virus-Host Interactions, The New York Academy of Sciences, 6/23/2015
• Development of a High-Content Platform for Identification of Novel CMV Therapeutics
  Gardner TJ, Cohen T, Noriega VM, Lau Z, Jain S, Kraus T, Duty A, Felsenfeld D, Moran T, Tortorella D, 5th International Congenital CMV Conference and 15th International CMV/Beta Herpes Virus Workshop, Brisbane, Australia, 4/23/2015
• Repurposing Small Molecule Drugs for Congenital Cytomegalovirus
  Cohen T, Gardner TJ, Noriega VM, Willams JD, Tortorella D, 17th Annual Child Health Research Day, Icahn School of Medicine at Mount Sinai, 4/16/2015
• CMV therapeutics discovery utilizing a high-content fluorescent assay.
  Gardner TJ, Cohen T, Redmann V, Noriega VM, Lau Z, Felsenfeld D, Moran T, Tortorella D, 39th International Herpesvirus Workshop, Kobe, Japan, 7/19/2014
• Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus life cycle.
  Gardner TJ*, Cohen T*, Redmann V, Lau Z, Felsenfeld D, Tortorella D, 19th Annual Medical Student Research Day, Icahn School of Medicine at Mount Sinai, 3/11/2014
• Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus life cycle.
  Gardner TJ*, Cohen T*, Redmann V, Lau Z, Felsenfeld D, Tortorella D, 24th Symposium on Virus-Host Interactions, New York Academy of Medicine, 1/9/2014
• Characterization of human cytomegalovirus gene expression during latent infection of CD14+ peripheral blood monocytes.
  Noriega VM, Haye KK, Gardner TJ, Cohen T, Subramanian S, Sachidanandam R, tenOever B, Tortorella D, 22nd Symposium on Virus-Host Interactions, New York Academy of Medicine, 1/10/2013
• Tracking Highly Conserved and Immunogenic Cross-Clade HIV CTL Epitopes Included in the GAIA HIV Vaccine Over Time.
  Sangare K, Koita O, Tounkara K, Koty Z, Moise L, Ardito M, Cohen T, Desrosiers J, DuPont R, Riochas M, Martin W, DeGroot A, AIDS Research and Human Retroviruses, 10/1/2010
• A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: iTEM (individualized T Cell Epitope Measure).
  Cohen T, Moise L, Ardito M, Martin W, De Groot AS, ACM International Conference on Bioinformatics and Computational Biology, Niagara Falls, NY, 8/2/2010
• Universal Flu Vaccines: Now more than Ever.
  De Groot AS, Malone R, Cohen T, McLaine E, Ardito M, Martin W, Vaccine Technology III, Nuevo Vallarta, Mexico, 6/6/2010
• Personalizing Immune Responses to Vaccines, Autoantigens, and Protein Therapeutics: The iTEM (individualized T Cell Epitope Measure) Tool.
  Cohen T, Ardito M, Martin W, De Groot AS, Vaccine Technology III, Nuevo Vallarta, Mexico, 6/6/2010
• EpiMatrix: Tool for Accelerated Epitope Selection and Vaccine Design.
  Ardito, M, Cohen T, Martin W, De Groot AS, Vaccine Technology III, Nuevo Vallarta, Mexico, 6/6/2010
• A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: iTEM (individualized T Cell Epitope Measure).
  Cohen T, Moise L, Ardito M, Martin W, De Groot AS, 13th annual conference on vaccine research, North Bethesda, MD, 4/26/2010
• Individualized T cell epitope measure (item): A new tool for vaccine design and personal therapeutics.
  Cohen T, Ardito M, Desrosiers J, Martin W, De Groot AS, Harnessing immunity to prevent and treat disease, Cold Spring Harbor Laboratory, 11/11/2009
• Immunoinformatic-discovered mycobacterium tuberculosis T-cell epitopes are immunogenic in HLA transgenic mice.
  Moise L, Tassone R, Cohen T, DuPont R, Martin W, Lee J, Kornfeld H, De Groot AS, Harnessing immunity to prevent and treat disease, Cold Spring Harbor Laboratory, 11/11/2009
• Effect of “Tregitopes” on T1D immune response in vitro and diabetes in NOD mice.
  De Groot AS, Moise L, Li X, Su Y, Yang W, Desrosiers J, Tassone R, Mehta P, Cohen T, Martin W, Scott DW, 1st International Conference on Immune Tolerance, Boston, MA, 10/25/2009
• Does Epstein-Barr virus activate natural regulatory T cells?
  Cohen TSD, Ardito M, Trehan S, Martin W, De Groot AS, Vaccine Development 2008, Pittsburgh, PA, 9/28/2008
• Join now to see all

Other

• IgA Deficiency in a Liver Transplant Patient 
  T Cohen and L Vasovic
  BBANYS Quarterly Volume 57 Number 3 - 7/18/2023